COVINO GREGORY F 4
4 · NOVAVAX INC · Filed Nov 18, 2020
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
COVINO GREGORY F
EVP, Chief Financial Officer
Transactions
- Award
Stock Option (Right to buy)
2020-11-16+8,200→ 8,200 totalExercise: $90.65Exp: 2030-11-16→ Common Stock (8,200 underlying) - Award
Restricted Stock Units
2020-11-16+7,300→ 7,300 total→ Common Stock (7,300 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F2]One-third (1/3) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on each of the first three (3) anniversaries of the November 16, 2020 grant date (the "Grant Date"), subject to continued employment through each such vesting date.
- [F3]Twenty-five percent (25%) of the shares subject to this option grant under the Plan will vest on the first anniversary of the Grant Date, and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.